Multiple endocrine neoplasia type 2A

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

3 events
Jul 2025RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid Cancer

Fujian Medical University

TrialNOT YET RECRUITING
Jul 2023Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations

University of Colorado, Denver — PHASE1, PHASE2

TrialACTIVE NOT RECRUITING
Aug 2022Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies

University of Virginia — NA

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Multiple endocrine neoplasia type 2A.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Multiple endocrine neoplasia type 2A.
Search all trials →
Search clinical trials for Multiple endocrine neoplasia type 2A

Recent News & Research

No recent news articles indexed yet for Multiple endocrine neoplasia type 2A.
Search PubMed for Multiple endocrine neoplasia type 2A

Browse all Multiple endocrine neoplasia type 2A news →

Specialist Network

Top 5 by expertise

View all Multiple endocrine neoplasia type 2A specialists →

Quick Actions